Radio and PodcastLive Radio & PodcastsScience & Medicine
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
Achieve Life Sciences is developing Cytisinicline for the treatment of smoking cessation. The drug has been available in Eastern Europe for years, but Achieve has taken the lead to bring this drug to market in developed...
Related Episodes
Continue listening to more episodes from Breaking Biotech.
112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
Apr 21, 2022 - 00:43:59
109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
Feb 22, 2022 - 00:33:42
108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD
Feb 7, 2022 - 00:37:28
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
Jan 9, 2022 - 00:42:53